Crossmark

Effectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study

Crossref DOI link: https://doi.org/10.1016/j.gastre.2022.12.007

Published Print: 2023-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Quera, Rodrigo

Córdova, Andrea

Núñez, Paulina

von Muhlenbrock, Christian
License Information

Text and Data Mining valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01

stm-asf valid from 2023-12-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety of high-dose dual therapy PPI-amoxicillin dual therapy for first-line Helicobacter pylori in Chile: Experience from the retrospective study

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2022.12.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2022.12.001

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below